Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, 7SL, cytoplasmic 211, pseudogene (RN7SL211P)** is a member of a large family of **7SL RNA-derived pseudogenes** in the human genome. 7SL RNA is the RNA component of the signal recognition particle (SRP), a ribonucleoprotein complex essential for targeting secretory proteins into the endoplasmic reticulum during translation. However, the pseudogene form, such as RN7SL211P, is a non-functional, typically truncated, genomic DNA sequence that arises from the reverse transcription and re-integration of 7SL RNA itself. Like most pseudogenes, RN7SL211P does *not* produce a functional product and is not known to have any direct biological role or therapeutic relevance. Pseudogenes can sometimes interfere with genetic analysis due to sequence similarity to their functional counterparts and may occasionally have regulatory effects, but RN7SL211P specifically has no established function or involvement in disease[2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 211, pseudogene (RN7SL211P).